> Detailanzeige

Doldi, Philipp Maximilian; Stolz, Lukas; Escher, Felix; Steffen, Julius; Gmeiner, Jonas; Roden, Daniel; Linnemann, Marie; Löw, Kornelia; Deseive, Simon; Stocker, Thomas J.; Orban, Martin; Theiss, Hans; Rizas, Konstantinos; Curta, Adrian; Sadoni, Sebastian; Buech, Joscha; Joskowiak, Dominik; Peterss, Sven; Hagl, Christian; Massberg, Steffen; Hausleiter, Jörg; Braun, Daniel

Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View
  • Beteiligte: Doldi, Philipp Maximilian; Stolz, Lukas; Escher, Felix; Steffen, Julius; Gmeiner, Jonas; Roden, Daniel; Linnemann, Marie; Löw, Kornelia; Deseive, Simon; Stocker, Thomas J.; Orban, Martin; Theiss, Hans; Rizas, Konstantinos; Curta, Adrian; Sadoni, Sebastian; Buech, Joscha; Joskowiak, Dominik; Peterss, Sven; Hagl, Christian; Massberg, Steffen; Hausleiter, Jörg; Braun, Daniel
  • Erschienen: MDPI AG, 2022
  • Erschienen in: Journal of Clinical Medicine, 11 (2022) 6, Seite 1561
  • Sprache: Englisch
  • DOI: 10.3390/jcm11061561
  • ISSN: 2077-0383
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Despite the rapid increase in experience and technological improvement, the incidence of conduction disturbances in patients undergoing transcatheter aortic valve replacement (TAVR) with the self-expandable CoreValve Evolut valve remains high. Recently, a cusp-overlap view (COP) implantation technique has been proposed for TAVR with self-expandable valves offering an improved visualization during valve expansion compared to the three-cusp view (TCV). This study aims to systematically analyze procedural outcomes of TAVR patients treated with the CoreValve Evolut valve using a COP compared to TCV in a high-volume center. The primary endpoint was technical success according the 2021 VARC-3 criteria. A total of 122 consecutive patients (61 pts. TCV: April 2019 to November 2020; 61 pts. COP: December 2020 to October 2021) that underwent TAVR with the CoreValve Evolut prosthesis were included in this analysis. Although there was no difference in the primary endpoint technical success between TCV and COP patients (93.4% vs. 90.2%, OR 0.65, 95% CI 0.16, 2.4, p = 0.51), we observed a significantly lower risk for permanent pacemaker implantation (PPI) among COP patients (TCV: 27.9% vs. COP: 13.1%, OR 0.39, 95% CI 0.15, 0.97, p = 0.047). Implantation of the CoreValve Evolut prosthesis using the COP might help to reduce the rate of PPI following TAVR.
  • Zugangsstatus: Freier Zugang